BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2986082)

  • 1. Vasopressin receptor subtypes in dorsal hindbrain and renal medulla.
    Cornett LE; Dorsa DM
    Peptides; 1985; 6(1):85-9. PubMed ID: 2986082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1, 2, 4, 7, and 8.
    Grzonka Z; Kasprzykowski F; Kojro E; Darlak K; Melin P; Fahrenholz F; Crause P; Boer R
    J Med Chem; 1986 Jan; 29(1):96-9. PubMed ID: 2416923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of (3H) arginine8 vasopressin binding to the rat renal medulla by guanine nucleotides.
    Cornett LE; Dorsa DM
    J Recept Res; 1986; 6(2):127-40. PubMed ID: 3522888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced binding of 3H-arginine8-vasopressin in the Brattleboro rat.
    Shewey LM; Dorsa DM
    Peptides; 1986; 7(4):701-4. PubMed ID: 3763443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
    Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
    Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of specific arginine-vasopressin binding sites of renal medulla membranes in lithium treated rats.
    Mitsui T; Ogura T; Ogawa N; Ota Z
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):201-8. PubMed ID: 3001884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a 3H-arginine8-vasopressin binding site in the cingulate gyrus of the rat pup.
    Szot P; Myers KM; Swank M; Dorsa DM
    Peptides; 1989; 10(6):1231-7. PubMed ID: 2622802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a specific, high affinity [3H]arginine8 vasopressin-binding site on liver microsomes from different strains of rat and the role of magnesium.
    Gopalakrishnan V; Triggle CR; Sulakhe PV; McNeill JR
    Endocrinology; 1986 Mar; 118(3):990-7. PubMed ID: 3004905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
    Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
    Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand.
    Trinder D; Stephenson JM; Gao X; Phillips PA; Risvanis J; Johnston CI
    Peptides; 1991; 12(6):1195-200. PubMed ID: 1815207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin receptors in human seminal vesicles: identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney.
    Maggi M; Baldi E; Genazzani AD; Giannini S; Natali A; Costantini A; Rodbard D; Serio M
    J Androl; 1989; 10(5):393-400. PubMed ID: 2592268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist.
    Phillips PA; Kelly JM; Abrahams JM; Grzonka Z; Paxinos G; Mendelsohn FA; Johnston CI
    J Hypertens Suppl; 1988 Dec; 6(4):S550-3. PubMed ID: 2977179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological action and binding sites for vasopressin on the mesenteric artery from normal and sodium-depleted rats.
    St-Louis J; Schiffrin EL
    Life Sci; 1984 Oct; 35(14):1489-95. PubMed ID: 6090837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific arginine vasopressin binding in particulate membrane from rat aorta.
    Pearlmutter AF; Szkrybalo M; Pettibone G
    Peptides; 1985; 6(3):427-31. PubMed ID: 2999725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and localization of 3H-arginine8-vasopressin binding to rat kidney and brain tissue.
    Dorsa DM; Majumdar LA; Petracca FM; Baskin DG; Cornett LE
    Peptides; 1983; 4(5):699-706. PubMed ID: 6140673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of vasopressin receptors of rat urinary bladder and spleen.
    Thibonnier M; Snajdar RM; Rapp JP
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H115-20. PubMed ID: 3014903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpropamide alters AVP-receptor binding of rat renal tubular membranes.
    Muta T; Takasugi M; Kuroiwa A
    Eur J Pharmacol; 1989 Jan; 159(2):191-4. PubMed ID: 2707308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
    Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
    Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the functional molecular size of vasopressin isoreceptors.
    Crause P; Boer R; Fahrenholz F
    FEBS Lett; 1984 Oct; 175(2):383-6. PubMed ID: 6090217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.